Literature DB >> 33311892

Telemedicine Improves Access to Hepatology Consultation with High Patient Satisfaction.

Ezequiel Mauro1, Sebastián Marciano1,2, María C Torres1, Juan D Roca3, Abel L Novillo4, Adrían Gadano1,2.   

Abstract

AIMS: Telemedicine between health care providers could be useful for improving the access to hepatology consultations, which is challenging in some regions. The primary objective of this study was to estimate the proportion of consultations that were resolved through a telemedicine program. Additionally, we evaluated patient satisfaction with this strategy.
METHODS: Consecutive telemedicine consultations made by non-hepatologist health care providers from different regions of Argentina to a specialty hepatology team were included. Participants and hepatologists used e-mail, teleconference systems, WhatsApp, or telephone to interact, depending on their preferences. Consultations were considered to be resolved through telemedicine when a diagnosis and an adequate follow-up were achieved without the need to refer the patient to a hepatologist or other specialist. Patient satisfaction with telemedicine was evaluated using the Patient Satisfaction Questionnaire Short Form and Telemedicine Satisfaction Questionnaire.
RESULTS: A total of 200 telemedicine consultations made by 24 physicians from 10 different provinces of Argentina were evaluated, of which 145 (73%; 95% CI: 66%-79%) were resolved through telemedicine. Practitioners specialities were as follows: family physicians, internists, gastroenterologists, infectious diseases, and obstetrics. The most frequent final diagnoses for those patients whose consultation was resolved through telemedicine were non-alcoholic fatty liver disease, viral hepatitis, and benign hepatic lesions. A high degree of patient satisfaction with telemedicine was observed in both questionnaires.
CONCLUSIONS: Our results show the effectiveness of telemedicine in hepatology, with high resolution rate of consultations and rapid access to experts' assessment. Additionally, a high degree of patient satisfaction was observed using prevalidated questionnaires.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ECHO, Extension for Community Healthcare Outcomes; HCC, hepatocellular carcinoma; IQR, interquartile range; NAFLD, nonalcoholic fatty liver disease; OR, odds ratios; PSQ-18, Patient Satisfaction Questionnaire short form; TSQ, Telemedicine Satisfaction Questionnaire; access; consultation; patient-centered care; primary health care; telemedicine

Year:  2020        PMID: 33311892      PMCID: PMC7719958          DOI: 10.1016/j.jceh.2020.04.017

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  21 in total

1.  Patient Satisfaction and Healthcare Utilization Using Telemedicine in Liver Transplant Recipients.

Authors:  Long B Le; Harman K Rahal; Matthew R Viramontes; Katherine G Meneses; Tien S Dong; Sammy Saab
Journal:  Dig Dis Sci       Date:  2018-12-05       Impact factor: 3.199

2.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

3.  Screening for liver fibrosis in the general population: a call for action.

Authors:  Pere Ginès; Isabel Graupera; Frank Lammert; Paolo Angeli; Llorenç Caballeria; Aleksander Krag; I Neil Guha; S Darwish Murad; Laurent Castera
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

Review 4.  Integration of Telemedicine Into Clinical Gastroenterology and Hepatology Practice.

Authors:  Raymond K Cross; Sunanda Kane
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-16       Impact factor: 11.382

5.  Validation of a questionnaire measuring patient satisfaction with general practitioner services.

Authors:  S Grogan; M Conner; P Norman; D Willits; I Porter
Journal:  Qual Health Care       Date:  2000-12

6.  Specialty Care Access Network-Extension of Community Healthcare Outcomes Model Program for Liver Disease Improves Specialty Care Access.

Authors:  Lisa M Glass; Akbar K Waljee; Heather McCurdy; Grace L Su; Anne Sales
Journal:  Dig Dis Sci       Date:  2017-10-17       Impact factor: 3.199

7.  Implementation of the ECHO® telementoring model for the treatment of patients with hepatitis C.

Authors:  Sebastián Marciano; Leila Haddad; Fernando Plazzotta; Ezequiel Mauro; Sergio Terraza; Sanjeev Arora; Karla Thornton; Beatriz Ríos; Carlos García Dans; Natalia Ratusnu; Liliana Calanni; José Allevato; María Ester Sirotinsky; Marcos Pedrosa; Adrián Gadano
Journal:  J Med Virol       Date:  2016-09-01       Impact factor: 2.327

8.  Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care.

Authors:  Sanjeev Arora; Summers Kalishman; Karla Thornton; Denise Dion; Glen Murata; Paulina Deming; Brooke Parish; John Brown; Miriam Komaromy; Kathleen Colleran; Arthur Bankhurst; Joanna Katzman; Michelle Harkins; Luis Curet; Ellen Cosgrove; Wesley Pak
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

9.  Virtual Consultations Through the Veterans Administration SCAN-ECHO Project Improves Survival for Veterans With Liver Disease.

Authors:  Grace L Su; Lisa Glass; Elliot B Tapper; Tony Van; Akbar K Waljee; Anne E Sales
Journal:  Hepatology       Date:  2018-11-15       Impact factor: 17.425

Review 10.  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Laurent Castera; Mireen Friedrich-Rust; Rohit Loomba
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

View more
  4 in total

Review 1.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

2.  Provider and Patient Satisfaction with Telemedicine Voice Therapy During the COVID-19 Pandemic.

Authors:  Mary E Kim; Lauren Timmons Sund; Mariah Morton; James Kim; Janet S Choi; M Eugenia Castro
Journal:  J Voice       Date:  2022-07-18       Impact factor: 2.300

Review 3.  Using Telehealth for Diagnosis and Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Hamid-Reza Moein; Elvis J Arteaga; Souvik Sarkar
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-04-29

4.  Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID-19 Pandemic.

Authors:  Nipun Verma; Saurabh Mishra; Surender Singh; Rajwant Kaur; Talwinder Kaur; Arka De; Madhumita Premkumar; Sunil Taneja; Ajay Duseja; Meenu Singh; Virendra Singh
Journal:  Hepatol Commun       Date:  2021-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.